Skip to main content

Google Ventures — Portfolio, Page 12

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

416
Companies
$15.7B
Total invested
$43.8M
Avg. check
42
Industries
Biotechnology 10Health Care 8Medical 7Artificial Intelligence (AI) 6Pharmaceutical 4Machine Learning 3+36 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 265288 of 416
Accent Therapeutics
January 2024

Accent Therapeutics is a biopharmaceutical company.

Biotechnology · Lexington$75.0M Series C
Polar Signals
January 2024

Polar Signals is a profiling platform designed to measure and understand performance over time.

Computer · Claymont$6.8M Seed
Comanche Biopharma
January 2024

Our purpose is to make every pregnancy around the world safer.

Biopharma · Concord$75.0M Series B
Moonwalk Biosciences
January 2024

Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.

Artificial Intelligence (AI) · San Francisco$57.0M Series A
Tome Biosciences
December 2023

Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.

Biotechnology · Watertown$213.0M Series A
Graft
October 2023

Our Modern AI platform enables anyone to build production-ready AI apps in a few clicks.

Artificial Intelligence (AI) · San FranciscoSeed
Censys
October 2023

Censys provides an internet intelligence platform for threat hunting and exposure management.

Cyber Security · Ann Arbor$50.0M Series C
Signos
October 2023

Signos pairs glucose data with an AI-enhanced app to bring visibility into metabolic function and guidance to drive health and weight loss.

Health Care · Burlingame$20.0M Series B
ROME Therapeutics
September 2023

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

Biotechnology · Cambridge$72.0M Series B
Context.ai
August 2023

Context.ai is the product analytics platform for LLM applications. We help businesses understand user behaviour and product performance.

Analytics · London$3.6M Seed
deepset
August 2023

deepset offers the open-source AI Orchestration framework, Haystack, and a cloud and on-premise platform for enterprise AI teams.

Artificial Intelligence (AI) · Berlin$29.6M Series B
Evelo Biosciences
July 2023

Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.

Biotechnology · Cambridge$25.5M Post Ipo Equity
Speedy Brand
July 2023

Speedy Brand provides generative AI-powered marketing content for SMBs.

Artificial Intelligence (AI) · Middletown$2.5M Pre-Seed
Typeface
June 2023

Typeface offers a generative AI application that provides streamlined and personalized content creation for enterprises.

Artificial Intelligence (AI) · Palo Alto$100.0M Series B
Delve Bio
June 2023

Delve Bio is a biotechnology company that provides molecular insights for the precision care of patients.

Biotechnology · San Francisco$35.0M Series A
Caraway
June 2023

Caraway is providing college women+ with integrated mental, reproductive, and physical healthcare.

Fitness · New York$16.8M Series A
Guidelight Health
June 2023

Guidelight Health creates an intensive outpatient and partial hospitalization program for clinical excellence.

Health Care · Glencoe$16.4M Seed
Bitterroot Bio
June 2023

Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.

Biotechnology · Palo Alto$145.0M Series A
oneNav
June 2023

OneNav provides a mobile positioning system intended for smartphones, wearables, and IoT tracking devices.

Internet of Things · Palo Alto$2.8M Series C
Urban Machine
June 2023

Urban Machine is a construction company that manufactures reclaims and co-creates locally sourced premium lumber products.

Building Material · Oakland$10K Grant
Air Protein
May 2023

Air Protein develops protein-enriched food made from CO2.

Biotechnology · Pleasanton$75.0M Series Unknown
OMass Therapeutics
May 2023

OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.

Life Science · Oxford$12.5M Series B
Kindbody
May 2023

Kindbody is a fertility clinic network and family-building benefits provider for employers.

Employee Benefits · New York$25.0M Series Unknown
Antiva Biosciences
April 2023

Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.

Biotechnology · Del Mar$53.0M Series E

Where Google Ventures invests

Biotechnology10
Health Care8
Medical7
Artificial Intelligence (AI)6
Pharmaceutical4
Machine Learning3

About Google Ventures's portfolio

How many companies has Google Ventures invested in?

Google Ventures has invested in 416 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Google Ventures invest in?

Google Ventures's top investment sectors include Biotechnology, Health Care, Medical, Artificial Intelligence (AI), Pharmaceutical. The firm invests across 42 different industry categories.

What is Google Ventures's largest investment?

Among tracked funding rounds, Tome Biosciences received $213.0M in a Series A round. Google Ventures's total known invested capital is $15.7B.

What is the average investment size for Google Ventures?

Google Ventures's average investment size is $43.8M across its portfolio of 416 companies.

What are Google Ventures's most recent investments?

Recent Google Ventures portfolio additions include Accent Therapeutics, Polar Signals, Comanche Biopharma, Moonwalk Biosciences, Tome Biosciences. These companies were founded in 2020 or later.

Reach the founders behind these 416 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →